Sort
21,281 grants matching “influenza”
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population
$1,100,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2017 · IP
Collaborative Research on Influenza, Coronavirus Disease 2019 (COVID-19), and Other Respiratory Pathogens in South Africa
$1,100,000Cheryl Cohen · National Health Laboratory Service · U01 · FY2021 · IP
Estimates of Influenza Vaccine Effectiveness
$1,100,000John Jay Treanor · University Of Rochester · U18 · FY2010 · IP
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network
$1,100,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · IP
Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells
$1,099,708Troy D Randall · University Of Alabama At Birmingham · R01 · FY2023 · AI
Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells
$1,099,708Troy D Randall · University Of Alabama At Birmingham · R01 · FY2021 · AI
Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells
$1,099,708Troy D Randall · University Of Alabama At Birmingham · R01 · FY2025 · AI
Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells
$1,099,708Troy D Randall · University Of Alabama At Birmingham · R01 · FY2024 · AI
Molecular Analysis and Lineage Tracing of Influenza-Specific, Lung-Resident Memory B Cells
$1,099,708Troy D Randall · University Of Alabama At Birmingham · R01 · FY2020 · AI
Oklahoma Center for Respiratory and Infectious Diseases
$1,098,507Lin Liu · Oklahoma State University Stillwater · P30 · FY2025 · GM
IMPACT OF RESPIRATORY RNA VIRUSES ON CELLULAR PATHWAYS
$1,098,305Mount Sinai School Of Medicine Of Nyu · P01 · FY2003 · AI
Phase II Trial of H7N9 Influenza Vaccines - VTEU
$1,098,151Karen L. Kotloff · University Of Maryland Baltimore · N01 · FY2014 · AI
Micro-Particle Delivery of a Potent Intracellular Adjuvant for a Universal Flu Vaccine
$1,097,998Jenny P.y. Ting · Univ Of North Carolina Chapel Hill · R01 · FY2023 · AI
Systems Biology Analysis of Influenza A Virus and Ebola Virus
$1,097,974Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2015 · AI
ULTRAFAST OPTICAL PROCESSES LABORATORY
$1,096,627Feng Gai · University Of Pennsylvania · P41 · FY2012 · GM
Recombinant Adenovirus Vector Vaccine Studies
$1,096,350Gary J Nabel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Viral Vector Core
$1,095,298Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIC · FY2018 · ES
Establishing Early Brain Signatures associated with Maternal Immune Activation Exposure
$1,094,475Marisa N Spann · Columbia University Health Sciences · R01 · FY2022 · MH
Influenza and Emerging Infectious Diseases
$1,094,375Richard Davey · Niaid Extramural Activities · Z01 · FY2007 · AI
The Incidence and Etiology of Influenza-Associated Community-Acquired Pneumonia i
$1,093,996Kathryn Margaret Edwards · Vanderbilt University · U18 · FY2011 · IP
Avian Influenza Viruses in the Environment:What is the Probability of Human Conta
$1,093,930David E Stallknecht · University Of Georgia · U19 · FY2008 · CI
Broad Spectrum Neutralizing Human Abs to SARS and Related Coronaviruses
$1,093,892Wayne A. Marasco · Dana-Farber Cancer Inst · R01 · FY2010 · AI
Developing and Applying Analytical Models of Influenza Transmission
$1,093,547Jelena Srebric · Univ Of Maryland, College Park · U19 · FY2025 · AI
Avian Influence Cooperative Research Centers-Human-Animal Inferface
$1,093,077Jeffery B. Bender · University Of Minnesota · U19 · FY2008 · CI
Enabling risk-based testing through characterization of environmentally induced immune dysregulation and susceptibility to the SARS-CoV2 virus and COVID-19
$1,090,900Florence Burleson · · N01 · FY2023 · ES